UK becomes the first country to approve antiviral COVID-19 pill
Image Credit: reuters
The UK has approved antiviral COVID-19 drug Lagevrio (molnupiravir) after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 following a stringent review.The drug is developed by Ridgeback Biotherapeutics and Merck Sharp and Dohme (MSD), Lagevrio works by interfering with the virus` replication.